中国生物工程杂志

［1］ Schiltz R L, Mizzen C A, Vassilev A, et al. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem, 1999, 274(3) :11891192. 
［2］ Jensen K, Shiels C, Freemont P S. PML protein isoforms and the RBCC/TRIM motif. Oncogene, 2001, 20(49) :72237233. 
［3］ Beech S J, Lethbridge K J, Killick N, et al. Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. Exp Cell Res, 2005, 307(1) :109117. 
［4］ Everett R D, ChelbiAlix M K. PML and PML nuclear bodies: implications in antiviral defence. Biochimie, 2007, 89(67) :819830. 
［5］ Negorev D, Maul G G. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene, 2001, 20(49) :72347242. 
［6］ Zhong S, Muller S, Ronchetti S, et al. Role of SUMO1modified PML in nuclear body formation. Blood, 2000, 95(9) :27482752. 
［7］ Cho H, Orphanides G, Sun X, et al. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol, 1998, 18(9) :53555363. 
［8］ Liu L, Scolnick D M, Trievel R C, et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol, 1999, 19(2) :12021209. 
［9］ Jin Y, Zeng S X, Dai M S, et al. MDM2 inhibits PCAF (p300/CREBbinding proteinassociated factor)mediated p53 acetylation. J Biol Chem, 2002, 277(34) :3083830843. 
［10］ Liu X, Tesfai J, Evrard Y A, et al. cMyc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem, 2003, 278(22) :2040520412. 
［11］ Masumi A, Wang I M, Lefebvre B, et al. The histone acetylase PCAF is a phorbolesterinducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol Cell Biol, 1999, 19(3) :18101820. 
［12］ Masumi A, Ozato K. Coactivator p300 acetylates the interferon regulatory factor2 in U937 cells following phorbol ester treatment. J Biol Chem, 2001, 276(24) :2097320980. 
［13］ Kurooka H, Honjo T. Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5. J Biol Chem, 2000, 275(22) :1721117220. 
［14］ Yao Y L, Yang W M, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol, 2001, 21(17) :59795991. 
［15］ Doucas V, Tini M, Egan D A, et al. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A, 1999, 96(6) :26272632. 
［16］ Guo A, Salomoni P, Luo J, et al. The function of PML in p53dependent apoptosis. Nat Cell Biol, 2000, 2(10) :730736. 
［17］ Wei X, Yu Z K, Ramalingam A, et al. Physical and functional interactions between PML and MDM2. J Biol Chem, 2003, 278(31) :2928829297. 
［18］ Zhong S, Salomoni P, Pandolfi P P. The transcriptional role of PML and the nuclear body. Nat Cell Biol, 2000, 2(5) :8590. 
［19］ Boisvert F M, Kruhlak M J, Box A K, et al. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol, 2001, 152(5) :10991106. 
［20］ Hayakawa F, Abe A, Kitabayashi I, et al. Acetylation of PML is involved in histone deacetylase inhibitormediated apoptosis. J Biol Chem, 2008, 283(36) :2442024425.